eli lilly tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Eli Lilly just issued a

Use as suggested or as advised by the health provider

We believe that sustainable health decisions, including the choice to donate plasma, should be rooted in science, empathy, and a transparent approach, values that are at the very heart of TrimRxs mission to support healthier lifestyles

Originally approved to improve glycemic control in type 2 diabetes, these agents have revolutionized the management of obesity and demonstrated profound cardioprotective and neuroprotective benefits

This improved glycemic control is particularly beneficial for individuals with type 2 diabetes, assisting in the management of their condition and reducing the risk of associated complications

Gaby AR

Based on our conversations with investors prior to the announcement, this amount and timing of bill buying exceeded both consensus, and my own expectations